Literature DB >> 8034706

Key ligand interface residues in tissue factor contribute independently to factor VIIa binding.

J R Schullek1, W Ruf, T S Edgington.   

Abstract

Scanning alanine mutagenesis of the cell surface protease receptor tissue factor suggested importance of residues Lys20, Ile22, Asp58, Arg135, and Phe140 for binding of ligand, the serine protease coagulation factor VIIa. Ligand binding by single alanine replacement mutants was characterized by functional assays which concordantly demonstrated a calculated 1-2.5 kcal/mol reduction in free energy of binding as a result of each of the mutations. Catalytic and proteolytic function appeared to be not impaired by the residue replacements, indicating that these residues are not specifically required for the catalytic enhancement of VIIa produced by the assembly with tissue factor. Multiple mutations were further combined in one mutant protein to assess whether these residues provide independent contacts with the ligand VIIa. The Lys20/Asp58 and the Arg135/Phe140 residue pairs did not independently contribute to the binding of ligand. In contrast, the combination with Ile22 consistently produced a further decrease in affinity for VIIa, demonstrating that this residue acts as an independent contact site for the ligand VIIa. The total contribution of the five residues to the free energy of binding of VIIa at 37 degrees C was calculated to be 5.4 kcal/mol representing approximately one-third of the total binding energy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034706

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Properties of spin and fluorescent labels at a receptor-ligand interface.

Authors:  R Owenius; M Osterlund; M Lindgren; M Svensson; O H Olsen; E Persson; P O Freskgård; U Carlsson
Journal:  Biophys J       Date:  1999-10       Impact factor: 4.033

2.  Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.

Authors:  S Dittmar; W Ruf; T S Edgington
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Fusion of the tissue factor extracellular domain to a tumour stroma specific single-chain fragment variable antibody results in an antigen-specific coagulation-promoting molecule.

Authors:  J F Rippmann; K Pfizenmaier; R Mattes; W J Rettig; D Moosmayer
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

4.  Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa.

Authors:  C D Dickinson; C R Kelly; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Spin and fluorescent probing of the binding interface between tissue factor and factor VIIa at multiple sites.

Authors:  R Owenius; M Osterlund; M Svensson; M Lindgren; E Persson; P O Freskgård; U Carlsson
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

6.  Tissue Factor residue Asp44 regulates catalytic function of the bound proteinase Factor VIIa.

Authors:  C R Kelly; J R Schullek; W Ruf; T S Edgington
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

7.  Carbohydrates and activity of natural and recombinant tissue factor.

Authors:  Jolanta Krudysz-Amblo; Mark E Jennings; Kenneth G Mann; Saulius Butenas
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

8.  Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization.

Authors:  M J Stone; W Ruf; D J Miles; T S Edgington; P E Wright
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

Review 9.  Structural biology of factor VIIa/tissue factor initiated coagulation.

Authors:  Kanagasabai Vadivel; S Paul Bajaj
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

Review 10.  Tissue factor structure and function.

Authors:  Saulius Butenas
Journal:  Scientifica (Cairo)       Date:  2012-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.